Abstract

Obstructive Sleep Apnea is a complex disorder and has the characteristic finding of collapse of the upper airway during sleep. The effects of OSA may be widespread and can affect the cardiovascular, pulmonary, and neurocognitive systems. OSA has higher prevalence in men than women. The clinical symptoms can help to identify patients with OSA but it is also common to have no signs and symptoms in the initial stages. Obesity can be a contributing factor for OSA. OSA is identified as a major factor for cardiovascular morbidity such a systemic and pulmonary hypertension, heart failure, atrial fibrillation, and other arrhythmias. The screening for OSA includes the use of symptom questionnaire, CBCT for airway measurements, and confirmed by polysomnography. The management primarily includes the use of continuous positive airway pressure, orthodontic options, and surgical options.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.